www.embopress.org/doi/full/10....
www.embopress.org/doi/full/10....
Link: rdcu.be/d2mjm
Link: rdcu.be/d2mjm
www.nature.com/articles/s41...
www.nature.com/articles/s41...
@reisesousalab.bsky.social et al implicate recruitment of phosphatase SHIP1 by receptor DNGR-1/CLEC9A in uncoupling of cross-presentation from inflammatory induction
www.embopress.org/doi/full/10....
@reisesousalab.bsky.social et al implicate recruitment of phosphatase SHIP1 by receptor DNGR-1/CLEC9A in uncoupling of cross-presentation from inflammatory induction
www.embopress.org/doi/full/10....
DNGR-1, or CLEC9A, most known as a cDC1 receptor for cross-presentation of dead-cell associated antigens - may play a role here.
🔬Great to see labour of love led by Ana finally out now in @jem.org.
Available open access:
hubs.la/Q03mg6Sc0
@reisesousalab.bsky.social
DNGR-1, or CLEC9A, most known as a cDC1 receptor for cross-presentation of dead-cell associated antigens - may play a role here.
🔬Great to see labour of love led by Ana finally out now in @jem.org.
Available open access:
hubs.la/Q03mg6Sc0
@reisesousalab.bsky.social
New questions: Does this trigger Ag-specific immunity in #infection, #vaccination & #autoimmunity? 🤯 (12/13)
New questions: Does this trigger Ag-specific immunity in #infection, #vaccination & #autoimmunity? 🤯 (12/13)
Developed smart #liposomes with polymer-based surfaces for targeted immune cell delivery: anti-CLEC9A antibodies, stable diABZI loading, in vivo efficacy.
A leap forward in #nanomedicine & #Polymer #Engineering. #Immunotherapy #DrugDelivery
Developed smart #liposomes with polymer-based surfaces for targeted immune cell delivery: anti-CLEC9A antibodies, stable diABZI loading, in vivo efficacy.
A leap forward in #nanomedicine & #Polymer #Engineering. #Immunotherapy #DrugDelivery
Link: rdcu.be/d30EL
Link: rdcu.be/d30EL
www.nature.com/articles/s41...
@natimmunol.bsky.social l @inflammasomelab.bsky.social
www.nature.com/articles/s41...
@natimmunol.bsky.social l @inflammasomelab.bsky.social
F-actin-rich filopodia crown pyroptotic corpses and bind to DNGR-1, to activate dendritic cells & drive immunity! 🦠
Huge congrats @inflammasomelab.bsky.social & all co-authors 👏🏻
@natimmunol.bsky.social
www.nature.com/articles/s41...
F-actin-rich filopodia crown pyroptotic corpses and bind to DNGR-1, to activate dendritic cells & drive immunity! 🦠
Huge congrats @inflammasomelab.bsky.social & all co-authors 👏🏻
@natimmunol.bsky.social
www.nature.com/articles/s41...
www.nature.com/articles/s41...
www.nature.com/articles/s41...
doi.org/10.1038/s415...
doi.org/10.1038/s415...
𝗗𝗡𝗚𝗥-𝟭 is expressed by type 1 conventional dendritic cells, and recognises F-actin exposed by dead cells, promoting cross-presentation to CD8 T cells.
But from previous work, we knew DNGR-1–deficient mice can still reject transplantable tumours…So what was it doing during tumour development? 🤔
𝗗𝗡𝗚𝗥-𝟭 is expressed by type 1 conventional dendritic cells, and recognises F-actin exposed by dead cells, promoting cross-presentation to CD8 T cells.
But from previous work, we knew DNGR-1–deficient mice can still reject transplantable tumours…So what was it doing during tumour development? 🤔
The paper also added experiments deleting MHC II from RORγt+ DCs or CLEC9A+ cDC1s. Again, this looks like reviewer driven expansion rather than something essential to the original study.
The paper also added experiments deleting MHC II from RORγt+ DCs or CLEC9A+ cDC1s. Again, this looks like reviewer driven expansion rather than something essential to the original study.